Learn More
Medchemexpress LLC GP531 | 142344-87-4 | 347.37 | 50 MG

Supplier: Medchemexpress LLC HYU0011650MG
GP531 is a potent, second-generation adenosine regulating agent. It is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia. It is effective at lower doses in reducing ischemic/reperfusion injury severity without inducing adverse hemodynamic effects.
- Reduces infarct size and anatomic no-reflow zone in rabbits
- Effective at lower doses in reducing ischemic/reperfusion injury severity
- Does not induce adverse hemodynamic effects like bradycardia and hypotension
- Decreases left ventricular end-diastolic pressure, end-diastolic volume, end-systolic volume, and end-diastolic wall stress in dogs with heart failure
- Increases left ventricular ejection fraction without increasing myocardial oxygen consumption
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.